--:--:--
⬤ LOW 28 Jul 2026, 12:47 UTC

FDA Clears CorVista® System PCWP Add-On as a Noninvasive Test For Elevated Pulmonary Capillary Wedge Pressure

The PCWP Add-On represents the third FDA clearance for the CorVista System, a novel cardiopulmonary platform used at the point of care Elevated pulmonary capillary wedge pressure (PCWP) is a key indicator of both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) The PCWP Add-On integrates into the […]
\
Terms of Service